“It's not that I'm so smart, it's just that I stay with problems longer. — Albert Einstein
- Predicting ICU needs
- Accelerating tech solutions
- Cancer & COVID-19
- PUDDLE HOPS: Health tech
May 5, 2021
Image by Nhemz for Shutterstock
Predicting deterioration in COVID-19 patients
Creating tech solutions in Louisville
A study out of The Ohio State University shows that the COVID-19 virus's DNA can persist up to a month in dust. They are still in the process of determining whether the dust can transmit the virus to humans.
Flyover Future has followed medical and tech news around COVID-19 from the beginning of the pandemic. We're adding coverage to this report related to health care innovation to feature more advances across Flyover Country.
- A clinical trial at The Ohio State University is using gene therapy in a new approach to help those suffering from chronic angina who can’t undergo stenting or coronary bypass surgery.
- Indy-based Eli Lilly is seeking first approval of an autoimmune drug for hair loss. The drug, baricitinib, spurred hair regrowth in patients with a severe form of alopecia areata in a second Phase 3 study.
Share stories, offer suggestions, or comment!